Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BARR

  • FDA Approval
  • Dec. 17, 2022, 14:58 UTC
  • 25
  • 0 comments

FDA approve CLONAZEPAM

Comment Full text

RUBICON

  • FDA Approval
  • Dec. 17, 2022, 14:58 UTC
  • 27
  • 0 comments

FDA approve DICYCLOMINE HYDROCHLORIDE

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Dec. 17, 2022, 14:58 UTC
  • 31
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

MYLAN

  • FDA Approval
  • Dec. 17, 2022, 14:58 UTC
  • 28
  • 0 comments

FDA approve LENALIDOMIDE

Comment Full text

ACTAVIS ELIZABETH

  • FDA Approval
  • Dec. 17, 2022, 14:58 UTC
  • 35
  • 0 comments

FDA approve OXAZEPAM

Comment Full text

AUROBINDO

  • FDA Approval
  • Dec. 17, 2022, 14:58 UTC
  • 30
  • 0 comments

FDA approve NEVIRAPINE

Comment Full text

ALVOGEN

  • FDA Approval
  • Dec. 17, 2022, 14:58 UTC
  • 35
  • 0 comments

FDA approve NEVIRAPINE

Comment Full text

CHANGZHOU PHARM

  • FDA Approval
  • Dec. 17, 2022, 14:58 UTC
  • 39
  • 0 comments

FDA approve TICAGRELOR

Comment Full text

HOFFMANN LA ROCHE

  • FDA Approval
  • Dec. 15, 2022, 18:28 UTC
  • 26
  • 0 comments

FDA approve CAPECITABINE

Comment Full text

GILEAD SCIENCES INC

  • FDA Approval
  • Dec. 15, 2022, 18:21 UTC
  • 26
  • 0 comments

FDA approve REMDESIVIR

Comment Full text
  • Previous
  • 921
  • 922
  • 923
  • 924
  • 925
  • Next

Search

News categories

  • Technical Exchange News(12263)
  • Event(6229)
  • SEC News(267573)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(155734)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin